-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
09
2024-08
Lean production starts with strong management. Since March, Keyuan Pharmaceutical (stock code: 301281.SZ) has established a Lean Promotion Committee to foster a company-wide lean mindset. Under the guidance of the group’s lean experts, the company has successfully implemented the principles of digital and intelligent lean manufacturing, introducing cutting-edge tools such as digital-empowered lean value-stream analysis. As a result, the benchmark factory has achieved remarkable improvements, marking a solid step forward on the journey toward enhancing quality, reducing costs, and boosting efficiency across the enterprise.
2024-08-09
05
2024-08
Recently, the international marketing team of Keyuan Pharmaceutical successfully concluded its exchange and research activities in the Southeast Asian market. Led by Chairman and President Jiang Hongsheng and Director of International Trade Shi Bin, the initiative included visits to existing clients, development of new business relationships, and exploration of market opportunities. These efforts not only deepened Keyuan Pharmaceutical's understanding and communication with the Southeast Asian market but also laid a solid foundation for the company to further expand its international operations.
2024-08-05
03
2024-08
Recently, the 2024 Active Pharmaceutical Ingredient Continuous Manufacturing Technology Exchange Conference was successfully held in Dunhua City, Jilin Province. The event brought together extensive industry expertise and collaborative efforts, fostering discussions on the latest advancements, key technological trends, and future prospects of continuous manufacturing, while also paving the way for partnerships and joint growth initiatives.
2024-08-03
25
2024-07
Another stop on youth—chasing dreams at Keyuan.
In this vibrant season, youth is like morning dew—glistening and pure, yet tinged with both reluctance and anticipation. For every management trainee, each new beginning is a courageous journey into the unknown, marking the magnificent start of yet another chapter in their youthful adventure.
2024-07-25
11
2024-07
Good News | Warmest congratulations to Keyuan Pharmaceutical for being selected as a "2024 Shandong Province Benchmark for Intelligent Transformation in the Chemical Industry"!
2024-07-11
11
2024-07
To recognize outstanding achievements, set exemplary role models, and inspire responsibility and action, Keyuan Pharmaceutical held its 2024 FDA Certification Recognition Meeting on July 10. The event celebrated the advanced teams and individuals, further motivating all Keyuan employees to embrace a spirit of unity, collaboration, and relentless determination—driving them forward with榜样力量 toward the achievement of this year’s goals.
2024-07-11
10
2024-07
During this event, the management trainees visited and learned at the group headquarters, aiming to gain a comprehensive understanding of Keyuan Pharmaceutical's corporate culture, its development journey, and future prospects through firsthand experience—thereby further inspiring their enthusiasm for work and sense of responsibility, and injecting fresh energy into the company's growth.
2024-07-10
03
2024-07
Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical and Chairman of Linuo Pharmaceutical, along with Li Zhaowen, Chairman of the Trade Union and Vice President of Keyuan Pharmaceutical, the company’s management team, and the newly joined Management Trainees, all attended this symposium. The atmosphere at the event was both enthusiastic and solemn, as participants received training on Keyuan Pharmaceutical’s development strategy and corporate culture, while collectively discussing the company’s future growth and individual career planning.
2024-07-03
20
2024-06
Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical, hosted an international VIP client symposium together with the company’s international marketing team. The event provided a platform for in-depth communication and exchange with partners from around the globe, aiming to strengthen relationships, foster mutual understanding, explore industry trends more thoroughly, stay attuned to the pulse of sector development, share research achievements and product insights, and jointly identify new opportunities for collaboration.
2024-06-20
18
2024-06
FDA stands for the U.S. Food and Drug Administration, an agency authorized by the U.S. Congress—acting as the federal government—to specifically oversee the quality and safety management of food and pharmaceutical products. Today, products such as food, drugs, cosmetics, and medical devices that have been certified by the FDA are globally recognized as effective and safe for human use, serving as a world-class benchmark for product quality and efficacy.
2024-06-18
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline